Ignite Creation Date:
2025-12-24 @ 12:42 PM
Ignite Modification Date:
2026-02-24 @ 11:00 AM
Study NCT ID:
NCT00096161
Status:
COMPLETED
Last Update Posted:
2020-01-31
First Post:
2004-11-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Lymphoblastic Leukemia | View |
| None | Acute Myeloid Leukemia | View |
| None | Chronic Lymphocytic Leukemia | View |
| None | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | View |
| None | Graft Versus Host Disease | View |
| None | Hodgkin Lymphoma | View |
| None | Myelodysplastic/Myeloproliferative Neoplasm | View |
| None | Non-Hodgkin Lymphoma | View |
| None | Plasma Cell Myeloma | View |
| None | Waldenstrom Macroglobulinemia | View |
Keywords: